Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / FundiShares Healthcare Innovation UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerDRDR(GBX) LSE
ETF Ticker2B78(EUR) F
ETF Ticker2B78.DE(EUR) CXE
ETF TickerDRDR.LS(GBX) CXE
ETF TickerHEAL.AS(EUR) CXE
ETF TickerHEAL.LS(USD) CXE
ETF TickerHEALz(USD) CXE
ETF TickerHEAL(EUR) ETF Plus
ETF TickerDRDR.L(GBP) LSE

Holdings detail for MRUS

Stock NameMerus BV
TickerMRUS(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINNL0011606264

Show aggregate MRUS holdings

News associated with MRUS

Merus N.V. (NASDAQ:MRUS) Receives Average Recommendation of “Buy” from Analysts
Merus N.V. (NASDAQ:MRUS – Get Free Report) has received an average recommendation of “Buy” from the twelve research firms that are covering the firm, Marketbeat.com reports. Eleven analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among brokerages that […] - 2025-09-04 03:06:58
Merus (NASDAQ:MRUS) Coverage Initiated at Alliance Global Partners
Research analysts at Alliance Global Partners started coverage on shares of Merus (NASDAQ:MRUS – Get Free Report) in a research note issued on Monday, MarketBeat reports. The firm set a “buy” rating and a $90.00 price target on the biotechnology company’s stock. Alliance Global Partners’ target price suggests a potential upside of 34.61% from the […] - 2025-08-27 02:30:45
Leerink Partnrs Estimates Merus’ Q3 Earnings (NASDAQ:MRUS)
Merus N.V. (NASDAQ:MRUS – Free Report) – Analysts at Leerink Partnrs dropped their Q3 2025 EPS estimates for Merus in a report issued on Wednesday, August 6th. Leerink Partnrs analyst A. Berens now forecasts that the biotechnology company will post earnings per share of ($1.50) for the quarter, down from their prior estimate of ($1.32). […] - 2025-08-12 02:46:48
Merus (NASDAQ:MRUS) Downgraded to Sell Rating by Wall Street Zen
Merus (NASDAQ:MRUS – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Sunday. A number of other research analysts have also issued reports on the company. Needham & Company LLC reiterated a “buy” rating and set a $75.00 […] - 2025-07-22 02:07:06
Wall Street Zen Upgrades Merus (NASDAQ:MRUS) to “Hold”
Merus (NASDAQ:MRUS – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Saturday. A number of other brokerages have also issued reports on MRUS. William Blair reaffirmed an “outperform” rating on shares of Merus in a research report on […] - 2025-07-14 03:40:50
Insider Selling: Merus N.V. (NASDAQ:MRUS) COO Sells $1,793,840.00 in Stock
Merus N.V. (NASDAQ:MRUS – Get Free Report) COO Peter B. Silverman sold 34,000 shares of the firm’s stock in a transaction dated Friday, June 20th. The shares were sold at an average price of $52.76, for a total value of $1,793,840.00. The sale was disclosed in a legal filing with the SEC, which is accessible […] - 2025-06-27 05:10:52
Merus N.V. (NASDAQ:MRUS) Receives $84.64 Average Price Target from Brokerages
Merus N.V. (NASDAQ:MRUS – Get Free Report) has been assigned a consensus rating of “Buy” from the fourteen analysts that are currently covering the firm, MarketBeat reports. Twelve equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 1-year target price […] - 2025-06-24 02:36:57
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 14,544 Shares of Merus (NASDAQ:MRUS)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Merus (NASDAQ:MRUS – Free Report) by 17.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 98,744 shares of the biotechnology company’s stock after purchasing an additional 14,544 shares […] - 2025-06-05 05:13:00
Merus Prices 5.26 Mln Shares At $57/Shr In Public Offering; To Raise Around $300 Mln
(RTTNews) - Merus N.V. (MRUS), a Dutch oncology company developing multispecific antibodies and antibody drug conjugates, Wednesday announced the pricing of an underwritten public offering of around 5.26 million shares, at a price of $57.00 per share. The gross proceeds from the - 2025-06-04 01:56:43
Merus N.V. Announces Pricing of $300 Million Public Offering of Common Shares
Merus N.V. announced a $300 million public offering of 5.26 million common shares to fund clinical development and research. - 2025-06-04 01:20:22
Analysts Anticipate 25% Gains Ahead For The Holdings of FHLC
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-29 08:03:59
Merus (NASDAQ:MRUS) Earns Buy Rating from Needham & Company LLC
Merus (NASDAQ:MRUS – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at Needham & Company LLC in a research report issued to clients and investors on Monday,Benzinga reports. They currently have a $75.00 target price on the biotechnology company’s stock. Needham & Company LLC’s price target points to a potential upside […] - 2025-05-21 03:03:18
Merus (NASDAQ:MRUS) Holdings Decreased by The Manufacturers Life Insurance Company
The Manufacturers Life Insurance Company reduced its stake in shares of Merus (NASDAQ:MRUS – Free Report) by 17.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 42,085 shares of the biotechnology company’s stock after selling 9,204 shares during the quarter. […] - 2025-05-12 05:36:50
Tudor Investment Corp ET AL Purchases Shares of 5,075 Merus (NASDAQ:MRUS)
Tudor Investment Corp ET AL bought a new stake in Merus (NASDAQ:MRUS – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 5,075 shares of the biotechnology company’s stock, valued at approximately $213,000. A number of other institutional investors and hedge […] - 2025-05-11 05:44:52
Tower Research Capital LLC TRC Decreases Stock Holdings in Merus (NASDAQ:MRUS)
Tower Research Capital LLC TRC decreased its stake in shares of Merus (NASDAQ:MRUS – Free Report) by 77.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,668 shares of the biotechnology company’s stock after selling 9,221 shares during the […] - 2025-05-09 05:21:09
Merus (NASDAQ:MRUS) Short Interest Update
Merus (NASDAQ:MRUS – Get Free Report) was the target of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 6,270,000 shares, a decrease of 15.5% from the March 31st total of 7,420,000 shares. Currently, 9.6% of the company’s shares are sold short. Based on […] - 2025-05-05 04:58:56
Merus (NASDAQ:MRUS) Earns “Outperform” Rating from William Blair
William Blair reaffirmed their outperform rating on shares of Merus (NASDAQ:MRUS – Free Report) in a report issued on Monday morning,RTT News reports. Several other analysts have also commented on the stock. Guggenheim reissued a “buy” rating and set a $109.00 target price on shares of Merus in a research note on Friday, March 28th. […] - 2025-04-29 04:54:48
Invesco Ltd. Grows Stock Position in Merus (NASDAQ:MRUS)
Invesco Ltd. lifted its holdings in Merus (NASDAQ:MRUS – Free Report) by 2.2% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 786,365 shares of the biotechnology company’s stock after purchasing an additional 16,712 shares during the period. Invesco Ltd. owned about 1.15% of Merus […] - 2025-04-18 05:18:50
HighTower Advisors LLC Has $337,000 Stock Position in Merus (NASDAQ:MRUS)
HighTower Advisors LLC lifted its position in Merus (NASDAQ:MRUS – Free Report) by 10.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,020 shares of the biotechnology company’s stock after buying an additional 789 shares during the period. HighTower […] - 2025-04-02 04:14:47
Guggenheim Reiterates Buy Rating for Merus (NASDAQ:MRUS)
Merus (NASDAQ:MRUS – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Guggenheim in a report issued on Tuesday,Benzinga reports. They presently have a $109.00 target price on the biotechnology company’s stock. Guggenheim’s price objective indicates a potential upside of 131.91% from the company’s previous close. Other research analysts also recently […] - 2025-03-20 04:55:00
Bank of America Has Lowered Expectations for Merus (NASDAQ:MRUS) Stock Price
Merus (NASDAQ:MRUS – Get Free Report) had its target price lowered by analysts at Bank of America from $73.00 to $70.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Bank of America‘s price objective indicates a potential upside of 47.12% from the […] - 2025-03-12 04:00:48
HC Wainwright Reaffirms “Buy” Rating for Merus (NASDAQ:MRUS)
Merus (NASDAQ:MRUS – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a note issued to investors on Monday,Benzinga reports. They currently have a $85.00 price objective on the biotechnology company’s stock. HC Wainwright’s price target would suggest a potential upside of 90.41% from the stock’s previous close. […] - 2025-03-05 04:32:51
William Blair Predicts Merus’ FY2028 Earnings (NASDAQ:MRUS)
Merus (NASDAQ:MRUS – Free Report) – William Blair issued their FY2028 EPS estimates for Merus in a report issued on Friday, February 28th. William Blair analyst M. Phipps expects that the biotechnology company will post earnings per share of ($3.58) for the year. William Blair has a “Outperform” rating on the stock. The consensus estimate […] - 2025-03-04 06:28:57
Merus (NASDAQ:MRUS) Given New $83.00 Price Target at Needham & Company LLC
Merus (NASDAQ:MRUS – Free Report) had its price objective lowered by Needham & Company LLC from $85.00 to $83.00 in a research note released on Friday morning,Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. A number of other equities analysts have also recently commented on the company. The Goldman […] - 2025-03-03 04:54:51
Merus (NASDAQ:MRUS) Shares Purchased by State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D grew its holdings in shares of Merus (NASDAQ:MRUS – Free Report) by 29.0% during the 4th quarter, HoldingsChannel reports. The firm owned 48,268 shares of the biotechnology company’s stock after buying an additional 10,842 shares during the period. State of New Jersey Common Pension Fund D’s holdings […] - 2025-02-24 06:42:49
Analysts Set Merus (NASDAQ:MRUS) PT at $85.92
Shares of Merus (NASDAQ:MRUS – Get Free Report) have been assigned a consensus recommendation of “Buy” from the sixteen research firms that are covering the stock, MarketBeat reports. Fourteen equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average twelve-month price […] - 2025-02-19 04:46:55
KBC Group NV Has $2.41 Million Stake in Merus (NASDAQ:MRUS)
KBC Group NV raised its position in Merus (NASDAQ:MRUS – Free Report) by 4,583.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 57,234 shares of the biotechnology company’s stock after purchasing an additional 56,012 shares during the quarter. KBC Group NV’s holdings in […] - 2025-02-02 07:28:57

iShares Healthcare Innovation UCITS ETF USD (Acc) MRUS holdings

DateNumber of MRUS Shares HeldBase Market Value of MRUS SharesLocal Market Value of MRUS SharesChange in MRUS Shares HeldChange in MRUS Base ValueCurrent Price per MRUS Share HeldPrevious Price per MRUS Share Held
2025-11-11 (Tuesday)76,226USD 7,278,058MRUS holding increased by 4573USD 7,278,0580USD 4,573 USD 95.48 USD 95.42
2025-11-10 (Monday)76,226USD 7,273,485MRUS holding increased by 14483USD 7,273,4850USD 14,483 USD 95.42 USD 95.23
2025-11-07 (Friday)76,226USD 7,259,002MRUS holding increased by 5336USD 7,259,0020USD 5,336 USD 95.23 USD 95.16
2025-11-06 (Thursday)76,226USD 7,253,666MRUS holding decreased by -1525USD 7,253,6660USD -1,525 USD 95.16 USD 95.18
2025-11-05 (Wednesday)76,226USD 7,255,191MRUS holding increased by 10672USD 7,255,1910USD 10,672 USD 95.18 USD 95.04
2025-11-04 (Tuesday)76,226USD 7,244,519MRUS holding increased by 19819USD 7,244,5190USD 19,819 USD 95.04 USD 94.78
2025-11-03 (Monday)76,226USD 7,224,700MRUS holding decreased by -6098USD 7,224,7000USD -6,098 USD 94.78 USD 94.86
2025-10-31 (Friday)76,226USD 7,230,798MRUS holding decreased by -15246USD 7,230,7980USD -15,246 USD 94.86 USD 95.06
2025-10-30 (Thursday)76,226USD 7,246,044MRUS holding increased by 19057USD 7,246,0440USD 19,057 USD 95.06 USD 94.81
2025-10-29 (Wednesday)76,226USD 7,226,987MRUS holding decreased by -6860USD 7,226,9870USD -6,860 USD 94.81 USD 94.9
2025-10-28 (Tuesday)76,226USD 7,233,847MRUS holding increased by 22867USD 7,233,8470USD 22,867 USD 94.9 USD 94.6
2025-10-27 (Monday)76,226USD 7,210,980MRUS holding decreased by -21343USD 7,210,9800USD -21,343 USD 94.6 USD 94.88
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MRUS by Blackrock for IE00BYZK4776

Show aggregate share trades of MRUS

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-24SELL-64694.88095.060 95.042USD -61,397 52.21 Loss of -27,669 on sale
2025-09-11BUY32469.80070.647 70.562USD 22,862 47.96
2025-07-08SELL-32352.33053.500 53.383USD -17,243 46.71 Loss of -2,156 on sale
2025-06-24SELL-32454.13054.810 54.742USD -17,736 46.28 Loss of -2,743 on sale
2025-06-23SELL-32452.74053.580 53.496USD -17,333 46.23 Loss of -2,354 on sale
2025-06-20BUY13,07653.10553.310 53.290USD 696,814 46.18
2025-06-11SELL-27055.05057.000 56.805USD -15,337 45.77 Loss of -2,980 on sale
2025-05-30SELL-27056.07056.550 56.502USD -15,256 45.02 Loss of -3,101 on sale
2025-05-21BUY27043.21044.560 44.425USD 11,995 44.70
2025-05-14SELL-1,62040.40041.910 41.759USD -67,650 44.82 Profit of 4,955 on sale
2025-04-30SELL-27045.51045.800 45.771USD -12,358 45.05 Loss of -194 on sale
2025-04-28SELL-27045.28045.580 45.550USD -12,299 45.05 Loss of -135 on sale
2025-04-25SELL-27043.57044.280 44.209USD -11,936 45.07 Profit of 231 on sale
2025-04-11SELL-1,63241.97042.120 42.105USD -68,715 45.26 Profit of 5,157 on sale
2025-04-08SELL-81334.89039.490 39.030USD -31,731 45.53 Profit of 5,281 on sale
2025-04-07SELL-56637.39037.620 37.597USD -21,280 45.62 Profit of 4,541 on sale
2025-03-31SELL-54242.09045.440 45.105USD -24,447 45.86 Profit of 410 on sale
2025-03-21SELL-54047.24048.720 48.572USD -26,229 45.84 Loss of -1,476 on sale
2025-03-17BUY1,72347.22048.690 48.543USD 83,640 45.76
2025-03-12SELL-26549.16049.710 49.655USD -13,159 45.66 Loss of -1,057 on sale
2025-02-28SELL-26647.09047.670 47.612USD -12,665 45.59 Loss of -538 on sale
2025-02-25BUY26544.40046.700 46.470USD 12,315 45.60
2025-02-20SELL-26647.63048.000 47.963USD -12,758 45.51 Loss of -653 on sale
2025-02-19BUY53245.07045.180 45.169USD 24,030 45.52
2025-02-18BUY26642.27043.100 43.017USD 11,443 45.58
2024-12-30SELL-52241.89042.385 42.335USD -22,099 48.41 Profit of 3,169 on sale
2024-12-06SELL-26344.65045.600 45.505USD -11,968 48.87 Profit of 885 on sale
2024-12-04SELL-26345.48546.866 46.728USD -12,289 49.17 Profit of 642 on sale
2024-12-03SELL-52646.21049.110 48.820USD -25,679 49.28 Profit of 242 on sale
2024-11-21SELL-26544.35545.760 45.619USD -12,089 50.85 Profit of 1,386 on sale
2024-11-20SELL-26942.93043.520 43.461USD -11,691 51.29 Profit of 2,106 on sale
2024-11-19SELL-26843.49045.015 44.862USD -12,023 51.75 Profit of 1,845 on sale
2024-11-18SELL-1,05644.27046.820 46.565USD -49,173 52.22 Profit of 5,967 on sale
2024-11-12SELL-26351.63052.830 52.710USD -13,863 52.25 Loss of -120 on sale
2024-11-07SELL-26354.50055.390 55.301USD -14,544 51.91 Loss of -892 on sale
2024-11-05SELL-52651.75051.945 51.925USD -27,313 51.81 Loss of -59 on sale
2024-10-28SELL-26452.82054.950 54.737USD -14,451 52.49 Loss of -593 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRUS

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19123,75515,565295,32441.9%
2025-09-1897,3164,160228,73742.5%
2025-09-17144,3271,098242,46559.5%
2025-09-16109,9602,131222,43449.4%
2025-09-15149,8900318,67947.0%
2025-09-12313,4555,537606,03651.7%
2025-09-11186,04117,755345,08153.9%
2025-09-1077,2990149,18451.8%
2025-09-09109,27712,250231,07547.3%
2025-09-08110,3000207,99053.0%
2025-09-05113,7432,003270,19242.1%
2025-09-0471,3900194,43536.7%
2025-09-03118,2361,764269,03743.9%
2025-09-02104,542485304,73834.3%
2025-08-2988,408602208,72042.4%
2025-08-28205,6791,769570,45436.1%
2025-08-2743,7270107,17140.8%
2025-08-2649,2210280,42017.6%
2025-08-2551,1610113,71745.0%
2025-08-22100,1567,575192,11152.1%
2025-08-2172,4115,956216,04233.5%
2025-08-2059,6600265,38522.5%
2025-08-1994,8490242,81639.1%
2025-08-1849,3072,689113,53643.4%
2025-08-1564,98410,335112,73357.6%
2025-08-1476,8440278,92427.6%
2025-08-13178,5061,001423,47642.2%
2025-08-1286,7181,133254,30134.1%
2025-08-1184,695390117,68072.0%
2025-08-08112,4221,666230,83448.7%
2025-08-07130,196179222,63858.5%
2025-08-06255,4360409,27962.4%
2025-08-05102,3195,000286,82235.7%
2025-08-0443,196067,78863.7%
2025-08-01111,3330277,02240.2%
2025-07-31164,449300435,71737.7%
2025-07-30114,7390179,11064.1%
2025-07-2969,9870152,83345.8%
2025-07-28117,8630253,63746.5%
2025-07-25170,5300303,99956.1%
2025-07-24254,6644,904482,53052.8%
2025-07-23145,1700217,50366.7%
2025-07-22139,563525302,77646.1%
2025-07-21287,1341,374573,96150.0%
2025-07-18269,9230465,09658.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.